New platform based on biology and nanotechnology carries mRNA directly to target cells

Tel Aviv University's Prof. Dan Peer and his team have developed a biological approach to directing nanocarriers loaded with protein 'game changers' to specific cells. Their groundbreaking method may prove useful in treating myriad malignancies, inflammatory diseases and rare genetic disorders.